Mohn Nutrition Research Laboratory, Department of Clinical Science, University of Bergen, N-5020 Bergen, Norway.
Mohn Nutrition Research Laboratory, Department of Clinical Science, University of Bergen, N-5020 Bergen, Norway; Hormone Laboratory, Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, N-5021 Bergen, Norway.
Clin Nutr. 2023 Jun;42(6):919-928. doi: 10.1016/j.clnu.2023.03.018. Epub 2023 Mar 30.
BACKGROUND: Ultra-processed foods (UPF) have become a staple of the diet in many countries, concomitant with increases in non-communicable diseases including cancer. AIM: The aim of this systematic literature review was to evaluate associations between the consumption of UPF and cancer risk. METHODS: A systematic literature search for observational studies investigating the association between cancer risk and UPF consumption, determined by the NOVA classification system, was performed. Random-effects meta-analyses were conducted. Independent review and risk of bias assessment was performed independently by the authors using the National Institutes of Health's Study Quality Assessment Tools. RESULTS: Eleven reports were identified, including eight retrospective case-control studies and three prospective cohorts. The outcome was risk of total cancer and/or one or more of the following cancers: colorectal, breast, prostate, pancreatic, chronic lymphocytic leukemia and central nervous system tumors. Nine studies reported a significant positive association between UPF intake and all the assessed cancers except prostate, after adjustment for confounding factors including obesity and total energy intake. A 10% increment in the diet's proportion of UPF was associated with increased risk of overall cancer (HR = 1.13, 95% CI 1.07 to 1.18) and breast cancer (HR = 1.11, 95% CI 1.01 to 1.21). In addition, a high intake of UPF was associated with increased risk of colorectal cancer (OR = 1.30, 95% CI 1.11 to 1.51) and pancreatic cancer (HR = 1.49, 95% CI 1.07 to 2.07). More modest associations were found for chronic lymphocytic leukemia and central nervous system tumors. Common limitations of several of the studies included no prior assessment of diet before known diagnosis (the case-control studies), higher participation rates among cases, and likely misclassification of several foods as UPF or non-UPF. CONCLUSION: In conclusion, the available suggestive evidence shows a consistent significant association between intake of UPF and the risk of overall and several cancers, including colorectal-, breast- and pancreatic cancer. These data may inform updated dietary guidelines, policy makers and the public towards improving public health.
背景:超加工食品(UPF)已成为许多国家饮食的主食,与此同时,包括癌症在内的非传染性疾病的发病率也有所上升。
目的:本系统文献综述旨在评估 UPF 消费与癌症风险之间的关联。
方法:对调查 UPF 消费与癌症风险之间关联的观察性研究进行了系统文献检索,这些研究是根据 NOVA 分类系统确定的。进行了随机效应荟萃分析。作者使用美国国立卫生研究院的研究质量评估工具独立进行了独立审查和偏倚风险评估。
结果:确定了 11 份报告,包括 8 项回顾性病例对照研究和 3 项前瞻性队列研究。结果是总癌症和/或以下一种或多种癌症的风险:结直肠癌、乳腺癌、前列腺癌、胰腺癌、慢性淋巴细胞白血病和中枢神经系统肿瘤。在调整肥胖和总能量摄入等混杂因素后,除前列腺癌外,有 9 项研究报告 UPF 摄入量与所有评估的癌症之间存在显著正相关。饮食中 UPF 比例增加 10%,总体癌症风险增加(HR=1.13,95%CI 1.07 至 1.18)和乳腺癌风险增加(HR=1.11,95%CI 1.01 至 1.21)。此外,大量摄入 UPF 与结直肠癌(OR=1.30,95%CI 1.11 至 1.51)和胰腺癌(HR=1.49,95%CI 1.07 至 2.07)风险增加相关。慢性淋巴细胞白血病和中枢神经系统肿瘤的相关性稍弱。几项研究的共同局限性包括在已知诊断之前没有对饮食进行预先评估(病例对照研究)、病例中较高的参与率,以及可能将几种食物错误地归类为 UPF 或非 UPF。
结论:总之,现有提示性证据表明,UPF 摄入与总体和几种癌症(包括结直肠癌、乳腺癌和胰腺癌)的风险之间存在一致的显著关联。这些数据可能为更新膳食指南、政策制定者和公众提供信息,以改善公众健康。
Am J Gastroenterol. 2024-6-1
Int J Environ Res Public Health. 2021-5-20
Cancers (Basel). 2025-6-20
Glob Health Res Policy. 2025-7-1
Pharmaceuticals (Basel). 2025-5-9